Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma
- 12 January 2021
- journal article
- research article
- Published by Springer Nature
- Vol. 5 (1) , 61-65
Abstract
T(11;22)(q13;q11)/CCND1-IGL resulted in truncation of the CCND1 3′ coding sequences in a case of blastoid variant mantle cell lymphoma. The translocation generated CCND1 with a C-terminal alteration, leading to negative CCND1 immunohistochemistry by SP4 monoclonal antibody.Keywords
This publication has 22 references indexed in Scilit:
- t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoformHaematologica, 2018
- Mantle Cell Lymphoma with t(11;22) (q13;q11.2) an indolent clinical variant?Leukemia & Lymphoma, 2018
- New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded BiopsiesJournal of Clinical Oncology, 2017
- Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulationHuman Pathology, 2017
- The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation indexHaematologica, 2012
- 3’UTR mediated regulation of the cyclin D1 proto-oncogeneCell Cycle, 2009
- Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphomaLeukemia, 2004
- VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcomeBlood, 2003
- A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene.1994
- Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocationBritish Journal of Haematology, 1993